Abaloparatide for osteoporosis, cost-effectiveness of PCSK9 inhibitors, review of aortic dissection, and more | Learning | The JAMA Network
[Skip to Content]
Sign In
Individual Sign In
Create an Account
Institutional Sign In
OpenAthens Shibboleth
Purchase Options:
[Skip to Content Landing]
Sign in or Create an Account to track your personal CME/MOC activities
0 Credit Audio 27 min 13 sec JAMA August 16, 2016

Abaloparatide for osteoporosis, cost-effectiveness of PCSK9 inhibitors, review of aortic dissection, and more

×